Minimally invasive versus open right hepatectomy: comparative study with propensity score matching analysis.
Comparative study
Hepatectomy
Hepatic neoplasms/surgery
Laparoscopy
Minimally invasive surgery
Propensity score
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
30 Oct 2020
30 Oct 2020
Historique:
received:
17
06
2020
accepted:
20
10
2020
entrez:
31
10
2020
pubmed:
1
11
2020
medline:
9
1
2021
Statut:
epublish
Résumé
Minimally invasive liver resections (MILRs) have been increasingly performed in recent years. However, the majority of MILRs are actually minor or limited resections of peripheral lesions. Due to the technical complexity major hepatectomies remain challenging for minimally invasive surgery. The aim of this study was to compare the short and long-term outcomes of patients undergoing minimally invasive right hepatectomies (MIRHs) with contemporary patients undergoing open right hepatectomies (ORHs) METHODS: Consecutive patients submitted to anatomic right hepatectomies between January 2013 and December 2018 in two tertiary referral centers were studied. Study groups were compared on an intention-to-treat basis after propensity score matching (PSM). Overall survival (OS) analyses were performed for the entire cohort and specific etiologies subgroups RESULTS: During study period 178 right hepatectomies were performed. After matching, 37 patients were included in MIRH group and 60 in ORH group. The groups were homogenous for all baseline characteristics. MIRHs had significant lower blood loss (400 ml vs. 500 ml, P = 0.01), lower rate of minor complications (13.5% vs. 35%, P = 0.03) and larger resection margins (10 mm vs. 5 mm, P = 0.03) when compared to ORHs. Additionally, a non-significant decrease in hospital stay (ORH 9 days vs. MIRH 7 days, P = 0.09) was observed. No differences regarding the use of Pringle's maneuver, operative time, overall morbidity or perioperative mortality were observed. OS was similar between the groups (P = 0.13). Similarly, no difference in OS was found in subgroups of patients with primary liver tumors (P = 0.09) and liver metastasis (P = 0.80). MIRHs are feasible and safe in experienced hands. Minimally invasive approach was associated with less blood loss, a significant reduction in minor perioperative complications, and did not negatively affect long-term outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Minimally invasive liver resections (MILRs) have been increasingly performed in recent years. However, the majority of MILRs are actually minor or limited resections of peripheral lesions. Due to the technical complexity major hepatectomies remain challenging for minimally invasive surgery. The aim of this study was to compare the short and long-term outcomes of patients undergoing minimally invasive right hepatectomies (MIRHs) with contemporary patients undergoing open right hepatectomies (ORHs) METHODS: Consecutive patients submitted to anatomic right hepatectomies between January 2013 and December 2018 in two tertiary referral centers were studied. Study groups were compared on an intention-to-treat basis after propensity score matching (PSM). Overall survival (OS) analyses were performed for the entire cohort and specific etiologies subgroups RESULTS: During study period 178 right hepatectomies were performed. After matching, 37 patients were included in MIRH group and 60 in ORH group. The groups were homogenous for all baseline characteristics. MIRHs had significant lower blood loss (400 ml vs. 500 ml, P = 0.01), lower rate of minor complications (13.5% vs. 35%, P = 0.03) and larger resection margins (10 mm vs. 5 mm, P = 0.03) when compared to ORHs. Additionally, a non-significant decrease in hospital stay (ORH 9 days vs. MIRH 7 days, P = 0.09) was observed. No differences regarding the use of Pringle's maneuver, operative time, overall morbidity or perioperative mortality were observed. OS was similar between the groups (P = 0.13). Similarly, no difference in OS was found in subgroups of patients with primary liver tumors (P = 0.09) and liver metastasis (P = 0.80).
CONCLUSIONS
CONCLUSIONS
MIRHs are feasible and safe in experienced hands. Minimally invasive approach was associated with less blood loss, a significant reduction in minor perioperative complications, and did not negatively affect long-term outcomes.
Identifiants
pubmed: 33126885
doi: 10.1186/s12893-020-00919-0
pii: 10.1186/s12893-020-00919-0
pmc: PMC7602349
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
260Références
J Hepatobiliary Pancreat Sci. 2016 May;23(5):283-8
pubmed: 26946065
J Laparoendosc Adv Surg Tech A. 2010 Feb;20(1):35-7
pubmed: 20059322
World J Gastroenterol. 2015 Jul 21;21(27):8441-51
pubmed: 26217097
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53
pubmed: 25242563
Surg Endosc. 2020 Nov;34(11):5030-5040
pubmed: 31820156
World J Surg. 2018 Aug;42(8):2627-2634
pubmed: 29417245
Int J Surg. 2019 Jan;61:1-10
pubmed: 30496866
Surgery. 2017 Mar;161(3):642-649
pubmed: 27884614
J Laparoendosc Adv Surg Tech A. 2017 Dec;27(12):1236-1244
pubmed: 28498007
Ann Surg. 2009 Nov;250(5):825-30
pubmed: 19916210
J Hepatobiliary Pancreat Sci. 2020 Jan;27(1):3-15
pubmed: 31419040
World J Surg. 2020 Mar;44(3):887-895
pubmed: 31748885
Br J Surg. 2015 Jun;102(7):796-804
pubmed: 25873161
HPB (Oxford). 2019 Jul;21(7):906-911
pubmed: 30617001
J Laparoendosc Adv Surg Tech A. 2016 Jun;26(6):457-64
pubmed: 27120254
Surg Endosc. 1996 Jul;10(7):758-61
pubmed: 8662435
Surgery. 2011 May;149(5):680-8
pubmed: 21316725
World J Gastrointest Surg. 2016 Jan 27;8(1):5-26
pubmed: 26843910
Ann Surg. 2014 Nov;260(5):916-21; discussion 921-2
pubmed: 25243552
BMC Cancer. 2019 Nov 6;19(1):1047
pubmed: 31694596
Surgery. 2018 May;163(5):985-995
pubmed: 29555197
Asian J Surg. 2019 Jan;42(1):19-31
pubmed: 30170946
Int J Surg. 2017 Aug;44:191-203
pubmed: 28583897
Ann Surg Oncol. 2017 Feb;24(2):558-559
pubmed: 27271928
Surg Endosc. 2018 Feb;32(2):712-719
pubmed: 28726140
J R Coll Surg Edinb. 1997 Aug;42(4):219-25
pubmed: 9276552
Ann Surg. 2009 Nov;250(5):856-60
pubmed: 19806057
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
HPB (Oxford). 2017 Sep;19(9):818-824
pubmed: 28599892
Surgery. 2015 Jun;157(6):1055-64
pubmed: 25769697
Ann Surg. 2015 Apr;261(4):619-29
pubmed: 25742461
Surg Endosc. 2016 Nov;30(11):4756-4764
pubmed: 26902613
Obstet Gynecol. 1991 Nov;78(5 Pt 2):956-8
pubmed: 1833688
World J Surg. 2016 Jun;40(6):1422-8
pubmed: 26913732
BMJ. 2019 Oct 23;367:l5657
pubmed: 31645336
Ann Surg Oncol. 2013 Apr;20(4):1266
pubmed: 23242817
J Hepatobiliary Pancreat Sci. 2016 Nov;23(11):721-734
pubmed: 27685870
Ann Surg. 2016 Apr;263(4):761-77
pubmed: 26700223
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):732-6
pubmed: 25098667